Birmingham PhD student takes new rapid Covid-19 test from idea to reality

This article originally appeared on the UKRI Biotechnology and Biological Sciences Research Council website.  Jake Carter, a PhD student at BHP founder-member the University of Birmingham, was in his last year when COVID-19 and the first England lockdown forced him to leave the lab and stay at home.  With the support of his supervisors, university … Continue reading “Birmingham PhD student takes new rapid Covid-19 test from idea to reality”

May news round-up

Thursday 20 May 2021 saw us mark International Clinical Trials Day with the launch of two new initiatives to help industry partners and NHS sites to restart and accelerate clinical research – ultimately benefitting patients. We also shared exciting news of new collaborative partnerships with pharmaceutical companies – and, needless to say, Covid-19 research continued … Continue reading “May news round-up”

Harnessing the power of mental health data science

Data Science is becoming one of the key factors driving healthcare with significant investment in this area. Whether it is through the use of health informatics of routinely collected health data, large scale web/ app-based participation in research or through the use of multiple cohort research studies, data science is seen as an important way … Continue reading “Harnessing the power of mental health data science”

Not just “one of those things”

Arri Coomarasamy, Professor of Gynaecology & Reproductive Medicine at the University of Birmingham and Director of Tommy’s National Centre for Miscarriage Research, discusses why urgent changes should be made to NHS policy and how appropriate care should be provided to all women who have experienced one or more miscarriages. In my clinic when I see … Continue reading “Not just “one of those things””

Why drug repurposing is the route of choice when speed is of the essence

The COVID-19 pandemic has rapidly changed the delivery of healthcare.  It has stimulated rapid innovation in medical diagnostics and equipment, and the manufacturing sector has responded with flexible, demand-led manufacturing of ventilators and PPE.  But the first round of clinical trials for COVID featured drugs that were already on the market, and aimed to repurpose … Continue reading “Why drug repurposing is the route of choice when speed is of the essence”